CCRM (Notch Therapeutics)

www.notchtx.com
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Proof of Concept
Fund:
Prospects
A Method for Generating Progenitor T-Cells from Stem and/or Progenitor Cells for Universal CAR-T Therapy

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.